Jou-Ku Chung

rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial

David Ley, Boubou Hallberg, Ingrid Hansen‐Pupp et al. · The Journal of Pediatrics · 2018 · 158 citations · Full text

Medicine, Nutrition, Pediatrics +17

A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA

Simon Jones, Catherine Breen, Fiona Heap et al. · Molecular Genetics and Metabolism · 2016 · 126 citations · Full text

Medicine, Neurology, Pharmacology +13

ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion

Jolanta M. Siller‐Matula, Yahye Merhi, Jean‐François Tanguay et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2012 · 68 citations · Full text

Medicine, Hematology, Pharmacology +14

Pharmacokinetics and Bioavailability of a Therapeutic Enzyme (Idursulfase) in Cynomolgus Monkeys after Intrathecal and Intravenous Administration

Hongsheng Xie, Jou-Ku Chung, Mary Ann Mascelli et al. · PLoS ONE · 2015 · 32 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Results of a first-in-human phase I study of SRF231, a fully human, high-affinity anti-CD47 antibody.

Amita Patnaik, Anna Spreafico, Alison M. Paterson et al. · Journal of Clinical Oncology · 2020 · 26 citations

Medicine, Oncology, Pharmacology +17